Surgical Innovations Group plc Total Assets
Surgical Innovations Group plc total assets. Based on the latest financial reports, Surgical Innovations Group plc (SUN) holds total assets worth GBX11.64 Million GBX (≈ $1.42K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Surgical Innovations Group plc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Surgical Innovations Group plc (1989–2025)
Total assets of Surgical Innovations Group plc from 1989 to 2025. This chart illustrates how Surgical Innovations Group plc's total assets have evolved over time, based on quarterly financial data. See Surgical Innovations Group plc stock quote for real-time trading data and today's change.
Surgical Innovations Group plc - Asset Composition Analysis
Surgical Innovations Group plc Total Assets Breakdown (December 2025)
Surgical Innovations Group plc total assets breakdown as of December 2025. Surgical Innovations Group plc's total assets of GBX11.64 Million consist of 43.8% current assets and 56.2% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 7.0% |
| Accounts Receivable | GBX1.75 Million | 15.1% |
| Inventory | GBX2.19 Million | 18.8% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX5.42 Million | 46.6% |
Asset Composition Trend (1989–2025)
This chart illustrates how Surgical Innovations Group plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Surgical Innovations Group plc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Surgical Innovations Group plc's current assets represent 43.8% of total assets in 2025, a decrease from 74.0% in 1989.
- Cash Position: Cash and equivalents constituted 7.0% of total assets in 2025, down from 67.5% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, an increase from 6.0% in 1989.
- Asset Diversification: The largest asset category is goodwill at 46.6% of total assets.
Surgical Innovations Group plc Competitors by Total Assets
Key competitors of Surgical Innovations Group plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$13.07 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
Surgical Innovations Group plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.48 | 1.88 | 3.79 |
| Quick Ratio | 0.85 | 0.83 | 2.85 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.66 Million | GBX2.48 Million | GBX6.43 Million |
Surgical Innovations Group plc - Advanced Valuation Insights
This section examines the relationship between Surgical Innovations Group plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.52 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.9% |
| Total Assets | GBX11.64 Million |
| Market Capitalization | $36.89K USD |
Valuation Analysis
Below Book Valuation: The market values Surgical Innovations Group plc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Surgical Innovations Group plc's assets decreased by 4.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Surgical Innovations Group plc (1989–2025)
The table below shows the annual total assets of Surgical Innovations Group plc from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | GBX11.64 Million ≈ $1.42K |
-4.88% |
| 2024-12-31 | GBX12.24 Million ≈ $1.49K |
-14.54% |
| 2023-12-31 | GBX14.32 Million ≈ $1.74K |
-8.18% |
| 2022-12-31 | GBX15.60 Million ≈ $1.90K |
-0.78% |
| 2021-12-31 | GBX15.72 Million ≈ $1.91K |
-3.82% |
| 2020-12-31 | GBX16.34 Million ≈ $1.99K |
+0.20% |
| 2019-12-31 | GBX16.31 Million ≈ $1.98K |
-13.38% |
| 2018-12-31 | GBX18.83 Million ≈ $2.29K |
+1.57% |
| 2017-12-31 | GBX18.54 Million ≈ $2.26K |
+171.28% |
| 2016-12-31 | GBX6.83 Million ≈ $831.50 |
-12.05% |
| 2015-12-31 | GBX7.77 Million ≈ $945.38 |
-31.08% |
| 2014-12-31 | GBX11.27 Million ≈ $1.37K |
-45.40% |
| 2013-12-31 | GBX20.65 Million ≈ $2.51K |
+13.09% |
| 2012-12-31 | GBX18.26 Million ≈ $2.22K |
-3.65% |
| 2011-12-31 | GBX18.95 Million ≈ $2.31K |
+39.95% |
| 2010-12-31 | GBX13.54 Million ≈ $1.65K |
+17.35% |
| 2009-12-31 | GBX11.54 Million ≈ $1.40K |
+3.88% |
| 2008-12-31 | GBX11.11 Million ≈ $1.35K |
+18.50% |
| 2007-12-31 | GBX9.37 Million ≈ $1.14K |
+138.99% |
| 2006-12-31 | GBX3.92 Million ≈ $477.19 |
+24.51% |
| 2005-12-31 | GBX3.15 Million ≈ $383.26 |
+8.32% |
| 2004-12-31 | GBX2.91 Million ≈ $353.82 |
+1.75% |
| 2003-12-31 | GBX2.86 Million ≈ $347.74 |
+23.83% |
| 2002-12-31 | GBX2.31 Million ≈ $280.82 |
+26.40% |
| 2001-12-31 | GBX1.83 Million ≈ $222.17 |
+9.01% |
| 2000-12-31 | GBX1.68 Million ≈ $203.80 |
-7.20% |
| 1999-12-31 | GBX1.80 Million ≈ $219.62 |
-23.55% |
| 1998-12-31 | GBX2.36 Million ≈ $287.27 |
+103.36% |
| 1997-12-31 | GBX1.16 Million ≈ $141.26 |
+62.83% |
| 1996-08-31 | GBX713.00K ≈ $86.75 |
-71.34% |
| 1995-08-31 | GBX2.49 Million ≈ $302.72 |
-37.24% |
| 1994-08-31 | GBX3.96 Million ≈ $482.30 |
-40.29% |
| 1993-08-31 | GBX6.64 Million ≈ $807.77 |
+133.52% |
| 1992-08-31 | GBX2.84 Million ≈ $345.91 |
-6.82% |
| 1991-08-31 | GBX3.05 Million ≈ $371.22 |
+122.86% |
| 1990-08-31 | GBX1.37 Million ≈ $166.57 |
-39.45% |
| 1989-08-31 | GBX2.26 Million ≈ $275.10 |
-- |
About Surgical Innovations Group plc
Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through SI Brand, Original Equipment Manufacturer (OEM), and Distribution segments. The company provides… Read more